October 5, 2015
Avita expands Compassionate Use IDE program for ReCell
FDA allows Avita to expand its Compassionate Use Investigational Device Exemption (IDE) program for ReCell.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
October 5, 2015
FDA OKs Alcon’s AcrySof IQ Aspheric IOL with the UltraSert Pre-loaded Delivery System for patients undergoing cataract surgery
Novartis’s Alcon has received US Food and Drug Administration (FDA) approval for its AcrySof IQ Aspheric IOL with the UltraSert Pre-loaded Delivery System for patients undergoing cataract surgery.
October 2, 2015
FDA: Accelerated approval for Keytruda for patients with advanced (NSCLC) lung cancer
accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC)
October 2, 2015
Pfizer acquisition of GlaxoSmithKline’s vaccines Nimenrix and Mencevax
Pfizer Inc. has announced that it has completed the acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax.
October 2, 2015
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept
Novartis company has announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen’s US-licensed Enbrel (etanercept) – a tumor necrosis factor alpha (TNF-alpha) inhibitor.
October 1, 2015
FDA Advises: Don’t use NATUREAL nor and Ultimate Herbal Slimcap weight loss programes
The Food and Drug Administration (FDA) is advising consumers not to purchase or use NATUREAL, a product promoted and sold for weight loss.
October 1, 2015
Bayer CropScience: Horticulture Symposium in Puerto Vallarta, Mexico
Bayer has announced that from September 30th to October first, Bayer CropScience is hosting over 175 industry professionals from over 15 different countries at its Horticulture Symposium in Puerto Vallarta, Mexico.
October 1, 2015
NIH totals $85M for BRAIN initiative in 2015
The National Institutes of Health has shared its second wave of grants to support the goals of the Brain Research through…
October 1, 2015
Pfizer:A Story Half Told Continues
Pfizer Inc., in partnership with five leading breast cancer advocacy organizations, has announced the next chapter of the Breast Cancer: A Story Half Told initiative, launched in 2014 to identify public misperceptions and gaps in knowledge surrounding metastatic breast cancer (MBC), the most advanced form of breast cancer.